Reports

Industry Research Reports

Global Human Prothrombin Complex Market Insights, Forecast to 2030

Global Human Prothrombin Complex Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published Date: 2024-04-07

Pages: 90 Pages

Report ld: 2709288

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Human Prothrombin Complex Market Size(US$)

den_QYR1
cagr

CAGR 2024-2030

11.8%

marketSize

Market Size,2030

USD 3,473.8

Million

Market Snapshot

Market Size in 2024 (Value)
US$ 1,778.9 million
Market Forecast in 2030(Value)
US$ 3,473.8 million
CAGR
11.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

The global Human Prothrombin Complex market is projected to grow from US$ 1778.9 million in 2024 to US$ 3473.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.8% during the forecast period.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

Report Covers:

This report presents an overview of global market for Human Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Human Prothrombin Complex, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Prothrombin Complex, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Hualan Biological
  • Meheco Xinxing Pharma

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • 500 IU/Vial
  • 600 IU/Vial
  • 1000 IU/Vial
  • Others

Segment by Application

  • Hemophilia B
  • Vitamin K Deficiency
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Sales (consumption), revenue of Human Prothrombin Complex in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

marn_i1

Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

marn_i1

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

marn_i1

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

marn_i1

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

marn_i1

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

marn_i1

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex sales, revenue, price, gross margin, and recent development, etc.

marn_i1

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

marn_i1

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 14: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Human Prothrombin Complex Product Introduction

1.2 Market by Type

1.2.1 Global Human Prothrombin Complex Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 500 IU/Vial

1.2.3 600 IU/Vial

1.2.4 1000 IU/Vial

1.2.5 Others

1.3 Market by Application

1.3.1 Global Human Prothrombin Complex Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hemophilia B

1.3.3 Vitamin K Deficiency

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Human Prothrombin Complex Sales Estimates and Forecasts 2019-2030

2.2 Global Human Prothrombin Complex Revenue by Region

2.2.1 Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Human Prothrombin Complex Revenue by Region (2019-2024)

2.2.3 Global Human Prothrombin Complex Revenue by Region (2025-2030)

2.2.4 Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)

2.3 Global Human Prothrombin Complex Sales Estimates and Forecasts 2019-2030

2.4 Global Human Prothrombin Complex Sales by Region

2.4.1 Global Human Prothrombin Complex Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Human Prothrombin Complex Sales by Region (2019-2024)

2.4.3 Global Human Prothrombin Complex Sales by Region (2025-2030)

2.4.4 Global Human Prothrombin Complex Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

muLu

3 Competition by Manufactures

3.1 Global Human Prothrombin Complex Sales by Manufacturers

3.1.1 Global Human Prothrombin Complex Sales by Manufacturers (2019-2024)

3.1.2 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Prothrombin Complex in 2023

3.2 Global Human Prothrombin Complex Revenue by Manufacturers

3.2.1 Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024)

3.2.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Human Prothrombin Complex Revenue in 2023

3.3 Global Key Players of Human Prothrombin Complex, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Human Prothrombin Complex Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Human Prothrombin Complex, Product Offered and Application

3.8 Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

muLu

4 Market Size by Type

4.1 Global Human Prothrombin Complex Sales by Type

4.1.1 Global Human Prothrombin Complex Historical Sales by Type (2019-2024)

4.1.2 Global Human Prothrombin Complex Forecasted Sales by Type (2025-2030)

4.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)

4.2 Global Human Prothrombin Complex Revenue by Type

4.2.1 Global Human Prothrombin Complex Historical Revenue by Type (2019-2024)

4.2.2 Global Human Prothrombin Complex Forecasted Revenue by Type (2025-2030)

4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)

4.3 Global Human Prothrombin Complex Price by Type

4.3.1 Global Human Prothrombin Complex Price by Type (2019-2024)

4.3.2 Global Human Prothrombin Complex Price Forecast by Type (2025-2030)

muLu

5 Market Size by Application

5.1 Global Human Prothrombin Complex Sales by Application

5.1.1 Global Human Prothrombin Complex Historical Sales by Application (2019-2024)

5.1.2 Global Human Prothrombin Complex Forecasted Sales by Application (2025-2030)

5.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)

5.2 Global Human Prothrombin Complex Revenue by Application

5.2.1 Global Human Prothrombin Complex Historical Revenue by Application (2019-2024)

5.2.2 Global Human Prothrombin Complex Forecasted Revenue by Application (2025-2030)

5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)

5.3 Global Human Prothrombin Complex Price by Application

5.3.1 Global Human Prothrombin Complex Price by Application (2019-2024)

5.3.2 Global Human Prothrombin Complex Price Forecast by Application (2025-2030)

muLu

6 US & Canada

6.1 US & Canada Human Prothrombin Complex Market Size by Type

6.1.1 US & Canada Human Prothrombin Complex Sales by Type (2019-2030)

6.1.2 US & Canada Human Prothrombin Complex Revenue by Type (2019-2030)

6.2 US & Canada Human Prothrombin Complex Market Size by Application

6.2.1 US & Canada Human Prothrombin Complex Sales by Application (2019-2030)

6.2.2 US & Canada Human Prothrombin Complex Revenue by Application (2019-2030)

6.3 US & Canada Human Prothrombin Complex Market Size by Country

6.3.1 US & Canada Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Human Prothrombin Complex Sales by Country (2019-2030)

6.3.3 US & Canada Human Prothrombin Complex Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

muLu

7 Europe

7.1 Europe Human Prothrombin Complex Market Size by Type

7.1.1 Europe Human Prothrombin Complex Sales by Type (2019-2030)

7.1.2 Europe Human Prothrombin Complex Revenue by Type (2019-2030)

7.2 Europe Human Prothrombin Complex Market Size by Application

7.2.1 Europe Human Prothrombin Complex Sales by Application (2019-2030)

7.2.2 Europe Human Prothrombin Complex Revenue by Application (2019-2030)

7.3 Europe Human Prothrombin Complex Market Size by Country

7.3.1 Europe Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Human Prothrombin Complex Sales by Country (2019-2030)

7.3.3 Europe Human Prothrombin Complex Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

muLu

8 China

8.1 China Human Prothrombin Complex Market Size

8.1.1 China Human Prothrombin Complex Sales (2019-2030)

8.1.2 China Human Prothrombin Complex Revenue (2019-2030)

8.2 China Human Prothrombin Complex Market Size by Application

8.2.1 China Human Prothrombin Complex Sales by Application (2019-2030)

8.2.2 China Human Prothrombin Complex Revenue by Application (2019-2030)

muLu

9 Asia (excluding China)

9.1 Asia Human Prothrombin Complex Market Size by Type

9.1.1 Asia Human Prothrombin Complex Sales by Type (2019-2030)

9.1.2 Asia Human Prothrombin Complex Revenue by Type (2019-2030)

9.2 Asia Human Prothrombin Complex Market Size by Application

9.2.1 Asia Human Prothrombin Complex Sales by Application (2019-2030)

9.2.2 Asia Human Prothrombin Complex Revenue by Application (2019-2030)

9.3 Asia Human Prothrombin Complex Sales by Region

9.3.1 Asia Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Human Prothrombin Complex Revenue by Region (2019-2030)

9.3.3 Asia Human Prothrombin Complex Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

muLu

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Human Prothrombin Complex Market Size by Type

10.1.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Human Prothrombin Complex Market Size by Application

10.2.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Country

10.3.1 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

muLu

11 Company Profiles

11.1 Takeda

11.1.1 Takeda Company Information

11.1.2 Takeda Overview

11.1.3 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Takeda Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Takeda Recent Developments

11.2 CSL

11.2.1 CSL Company Information

11.2.2 CSL Overview

11.2.3 CSL Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 CSL Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 CSL Recent Developments

11.3 Grifols

11.3.1 Grifols Company Information

11.3.2 Grifols Overview

11.3.3 Grifols Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Grifols Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Grifols Recent Developments

11.4 Octapharma

11.4.1 Octapharma Company Information

11.4.2 Octapharma Overview

11.4.3 Octapharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Octapharma Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Octapharma Recent Developments

11.5 Hualan Biological

11.5.1 Hualan Biological Company Information

11.5.2 Hualan Biological Overview

11.5.3 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Hualan Biological Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Hualan Biological Recent Developments

11.6 Meheco Xinxing Pharma

11.6.1 Meheco Xinxing Pharma Company Information

11.6.2 Meheco Xinxing Pharma Overview

11.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Meheco Xinxing Pharma Recent Developments

muLu

12 Industry Chain and Sales Channels Analysis

12.1 Human Prothrombin Complex Industry Chain Analysis

12.2 Human Prothrombin Complex Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Human Prothrombin Complex Production Mode & Process

12.4 Human Prothrombin Complex Sales and Marketing

12.4.1 Human Prothrombin Complex Sales Channels

12.4.2 Human Prothrombin Complex Distributors

12.5 Human Prothrombin Complex Customers

muLu

13 Market Dynamics

13.1 Human Prothrombin Complex Industry Trends

13.2 Human Prothrombin Complex Market Drivers

13.3 Human Prothrombin Complex Market Challenges

13.4 Human Prothrombin Complex Market Restraints

muLu

14 Key Findings in The Global Human Prothrombin Complex Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Human Prothrombin Complex Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 500 IU/Vial
Table 3. Major Manufacturers of 600 IU/Vial
Table 4. Major Manufacturers of 1000 IU/Vial
Table 5. Major Manufacturers of Others
Table 6. Global Human Prothrombin Complex Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Human Prothrombin Complex Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Human Prothrombin Complex Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Human Prothrombin Complex Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Human Prothrombin Complex Revenue Market Share by Region (2019-2024)
Table 11. Global Human Prothrombin Complex Revenue Market Share by Region (2025-2030)
Table 12. Global Human Prothrombin Complex Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Human Prothrombin Complex Sales by Region (2019-2024) & (K Units)
Table 14. Global Human Prothrombin Complex Sales by Region (2025-2030) & (K Units)
Table 15. Global Human Prothrombin Complex Sales Market Share by Region (2019-2024)
Table 16. Global Human Prothrombin Complex Sales Market Share by Region (2025-2030)
Table 17. Global Human Prothrombin Complex Sales by Manufacturers (2019-2024) & (K Units)
Table 18. Global Human Prothrombin Complex Sales Share by Manufacturers (2019-2024)
Table 19. Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Human Prothrombin Complex Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Human Prothrombin Complex, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Human Prothrombin Complex Price by Manufacturers 2019-2024 (M USD/Unit)
Table 23. Global Human Prothrombin Complex Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2023)
Table 25. Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Human Prothrombin Complex, Product Offered and Application
Table 27. Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)
Table 30. Global Human Prothrombin Complex Sales by Type (2025-2030) & (K Units)
Table 31. Global Human Prothrombin Complex Sales Share by Type (2019-2024)
Table 32. Global Human Prothrombin Complex Sales Share by Type (2025-2030)
Table 33. Global Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Human Prothrombin Complex Revenue Share by Type (2019-2024)
Table 36. Global Human Prothrombin Complex Revenue Share by Type (2025-2030)
Table 37. Human Prothrombin Complex Price by Type (2019-2024) & (M USD/Unit)
Table 38. Global Human Prothrombin Complex Price Forecast by Type (2025-2030) & (M USD/Unit)
Table 39. Global Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)
Table 40. Global Human Prothrombin Complex Sales by Application (2025-2030) & (K Units)
Table 41. Global Human Prothrombin Complex Sales Share by Application (2019-2024)
Table 42. Global Human Prothrombin Complex Sales Share by Application (2025-2030)
Table 43. Global Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Human Prothrombin Complex Revenue Share by Application (2019-2024)
Table 46. Global Human Prothrombin Complex Revenue Share by Application (2025-2030)
Table 47. Human Prothrombin Complex Price by Application (2019-2024) & (M USD/Unit)
Table 48. Global Human Prothrombin Complex Price Forecast by Application (2025-2030) & (M USD/Unit)
Table 49. US & Canada Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)
Table 50. US & Canada Human Prothrombin Complex Sales by Type (2025-2030) & (K Units)
Table 51. US & Canada Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)
Table 54. US & Canada Human Prothrombin Complex Sales by Application (2025-2030) & (K Units)
Table 55. US & Canada Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Human Prothrombin Complex Sales by Country (2019-2024) & (K Units)
Table 61. US & Canada Human Prothrombin Complex Sales by Country (2025-2030) & (K Units)
Table 62. Europe Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)
Table 63. Europe Human Prothrombin Complex Sales by Type (2025-2030) & (K Units)
Table 64. Europe Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)
Table 67. Europe Human Prothrombin Complex Sales by Application (2025-2030) & (K Units)
Table 68. Europe Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Human Prothrombin Complex Sales by Country (2019-2024) & (K Units)
Table 74. Europe Human Prothrombin Complex Sales by Country (2025-2030) & (K Units)
Table 75. China Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)
Table 76. China Human Prothrombin Complex Sales by Type (2025-2030) & (K Units)
Table 77. China Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)
Table 80. China Human Prothrombin Complex Sales by Application (2025-2030) & (K Units)
Table 81. China Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)
Table 84. Asia Human Prothrombin Complex Sales by Type (2025-2030) & (K Units)
Table 85. Asia Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)
Table 88. Asia Human Prothrombin Complex Sales by Application (2025-2030) & (K Units)
Table 89. Asia Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Human Prothrombin Complex Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Human Prothrombin Complex Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Human Prothrombin Complex Sales by Region (2019-2024) & (K Units)
Table 95. Asia Human Prothrombin Complex Sales by Region (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Human Prothrombin Complex Sales by Type (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Human Prothrombin Complex Sales by Application (2025-2030) & (K Units)
Table 102. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Prothrombin Complex Sales by Country (2019-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Human Prothrombin Complex Sales by Country (2025-2030) & (K Units)
Table 109. Takeda Company Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)
Table 112. Takeda Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Takeda Recent Developments
Table 114. CSL Company Information
Table 115. CSL Description and Major Businesses
Table 116. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)
Table 117. CSL Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. CSL Recent Developments
Table 119. Grifols Company Information
Table 120. Grifols Description and Major Businesses
Table 121. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)
Table 122. Grifols Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Grifols Recent Developments
Table 124. Octapharma Company Information
Table 125. Octapharma Description and Major Businesses
Table 126. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)
Table 127. Octapharma Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Octapharma Recent Developments
Table 129. Hualan Biological Company Information
Table 130. Hualan Biological Description and Major Businesses
Table 131. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)
Table 132. Hualan Biological Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Hualan Biological Recent Developments
Table 134. Meheco Xinxing Pharma Company Information
Table 135. Meheco Xinxing Pharma Description and Major Businesses
Table 136. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)
Table 137. Meheco Xinxing Pharma Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Meheco Xinxing Pharma Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Human Prothrombin Complex Distributors List
Table 142. Human Prothrombin Complex Customers List
Table 143. Human Prothrombin Complex Market Trends
Table 144. Human Prothrombin Complex Market Drivers
Table 145. Human Prothrombin Complex Market Challenges
Table 146. Human Prothrombin Complex Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Prothrombin Complex Market Share by Type in 2023 & 2030
Figure 4. 500 IU/Vial Product Picture
Figure 5. 600 IU/Vial Product Picture
Figure 6. 1000 IU/Vial Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Prothrombin Complex Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Human Prothrombin Complex Market Share by Application in 2023 & 2030
Figure 10. Hemophilia B
Figure 11. Vitamin K Deficiency
Figure 12. Others
Figure 13. Human Prothrombin Complex Report Years Considered
Figure 14. Global Human Prothrombin Complex Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Prothrombin Complex Revenue 2019-2030 (US$ Million)
Figure 16. Global Human Prothrombin Complex Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)
Figure 18. Global Human Prothrombin Complex Sales 2019-2030 ((K Units)
Figure 19. Global Human Prothrombin Complex Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Human Prothrombin Complex Sales YoY (2019-2030) & (K Units)
Figure 21. US & Canada Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Human Prothrombin Complex Sales YoY (2019-2030) & (K Units)
Figure 23. Europe Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Human Prothrombin Complex Sales YoY (2019-2030) & (K Units)
Figure 25. China Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Human Prothrombin Complex Sales YoY (2019-2030) & (K Units)
Figure 27. Asia (excluding China) Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Prothrombin Complex Sales YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Human Prothrombin Complex Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Prothrombin Complex in the World: Market Share by Human Prothrombin Complex Revenue in 2023
Figure 32. Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)
Figure 34. Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 35. Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)
Figure 36. Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Human Prothrombin Complex Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Human Prothrombin Complex Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Human Prothrombin Complex Revenue Share by Country (2019-2030)
Figure 42. US & Canada Human Prothrombin Complex Sales Share by Country (2019-2030)
Figure 43. U.S. Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Human Prothrombin Complex Sales Market Share by Type (2019-2030)
Figure 46. Europe Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 47. Europe Human Prothrombin Complex Sales Market Share by Application (2019-2030)
Figure 48. Europe Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 49. Europe Human Prothrombin Complex Revenue Share by Country (2019-2030)
Figure 50. Europe Human Prothrombin Complex Sales Share by Country (2019-2030)
Figure 51. Germany Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 52. France Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 53. U.K. Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 56. China Human Prothrombin Complex Sales Market Share by Type (2019-2030)
Figure 57. China Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 58. China Human Prothrombin Complex Sales Market Share by Application (2019-2030)
Figure 59. China Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 60. Asia Human Prothrombin Complex Sales Market Share by Type (2019-2030)
Figure 61. Asia Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 62. Asia Human Prothrombin Complex Sales Market Share by Application (2019-2030)
Figure 63. Asia Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 64. Asia Human Prothrombin Complex Revenue Share by Region (2019-2030)
Figure 65. Asia Human Prothrombin Complex Sales Share by Region (2019-2030)
Figure 66. Japan Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 70. India Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Prothrombin Complex Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Human Prothrombin Complex Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Human Prothrombin Complex Sales Share by Country (2019-2030)
Figure 77. Brazil Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 82. Human Prothrombin Complex Value Chain
Figure 83. Human Prothrombin Complex Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share?zhanKai
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 11.8% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2024 to 2030?shouQi
What was the global market size of Human Prothrombin Complex in 2030?shouQi
What was the global market size of Human Prothrombin Complex in 2024?shouQi
Which companies rank high in the global Human Prothrombin Complex market?shouQi
den_biaoTiZhungShi

Related Reports

Global Human Prothrombin Complex Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published Date: 2024-04-07

Pages: 90 Pages

Report ld: 2709288

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now